Tumor Necrosis Factor- Antagonism Improves Vasodilation During Hyperinsulinemia in Metabolic Syndrome

Diabetes Care - United States
doi 10.2337/dc08-0219
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Tumor Necrosis Factor Receptor 1 Associated Periodic Syndrome

2020English

Tumor Necrosis Factor

2004English

Coupling Tumor Necrosis Factor-Α With αVIntegrin Ligands Improves Its Antineoplastic Activity

Cancer Research
Cancer ResearchOncology
2004English

Transforming Growth Factor-Β Receptor Antagonism Attenuates Myocardial Fibrosis in Mice With Cardiac-Restricted Overexpression of Tumor Necrosis Factor

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2007English

Adipose Tissue Gene Expression of Adiponectin, Tumor Necrosis Factor-Α and Leptin in Metabolic Syndrome Patients With Coronary Artery Disease

Internal Medicine
Internal MedicineMedicine
2011English

Effect of Obesity and Metabolic Syndrome on Hypoxic Vasodilation

European Journal of Applied Physiology
Sports MedicinePublic HealthSports ScienceEnvironmentalOrthopedicsMedicinePhysiologyOccupational Health
2011English

Selective Improvement of Tumor Necrosis Factor Capture in a Cytokine Hemoadsorption Device Using Immobilized Anti-Tumor Necrosis Factor

Journal of Biomedical Materials Research - Part B Applied Biomaterials
Biomedical EngineeringBiomaterials
2010English

Tumor Necrosis Factor- Blocker Induced Tuberculosis

Journal of Rheumatology
RheumatologyAllergyImmunology
2010English

Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis

Archives of Dermatology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy